These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9916094)

  • 1. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.
    Pascale JM; Shaw MM; Durant PJ; Amador AA; Bartlett MS; Smith JW; Gregory RL; McLaughlin GL
    Infect Immun; 1999 Feb; 67(2):805-9. PubMed ID: 9916094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.
    Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE
    Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.
    Zheng M; Shellito JE; Marrero L; Zhong Q; Julian S; Ye P; Wallace V; Schwarzenberger P; Kolls JK
    J Clin Invest; 2001 Nov; 108(10):1469-74. PubMed ID: 11714738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
    Smulian AG; Sullivan DW; Theus SA
    Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
    Samuelson DR; de la Rua NM; Charles TP; Ruan S; Taylor CM; Blanchard EE; Luo M; Ramsay AJ; Shellito JE; Welsh DA
    J Immunol; 2016 Mar; 196(6):2655-65. PubMed ID: 26864029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.
    Gigliotti F; Wiley JA; Harmsen AG
    Infect Immun; 1998 Jul; 66(7):3179-82. PubMed ID: 9632583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with Pneumocystis carinii A12
    Tong T; Wang Z; Xu Y; Shen J
    BMC Immunol; 2021 Jun; 22(1):40. PubMed ID: 34174820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
    Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260
    [No Abstract]   [Full Text] [Related]  

  • 9. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.
    Lund FE; Schuer K; Hollifield M; Randall TD; Garvy BA
    J Immunol; 2003 Aug; 171(3):1423-30. PubMed ID: 12874234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
    Beck JM; Warnock ML; Curtis JL; Sniezek MJ; Arraj-Peffer SM; Kaltreider HB; Shellito JE
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4
    Rapaka RR; Dai G; Zheng M; Kolls JK
    Infect Immun; 2019 Jul; 87(7):. PubMed ID: 31010812
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice.
    Beck JM; Newbury RL; Palmer BE; Warnock ML; Byrd PK; Kaltreider HB
    J Lab Clin Med; 1996 Nov; 128(5):477-87. PubMed ID: 8900290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis carinii antigen detection in rat serum and lung lavage.
    McNabb SJ; Graves DC; Kosanke SD; Moyer MJ; Ivey MH
    J Clin Microbiol; 1988 Sep; 26(9):1763-71. PubMed ID: 3263387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.
    Harmsen AG; Chen W; Gigliotti F
    Infect Immun; 1995 Jul; 63(7):2391-5. PubMed ID: 7790048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.
    Olivera N; Castuma CE; Hozbor D; Gaillard ME; Rumbo M; Gómez RM
    Biomed Res Int; 2014; 2014():421486. PubMed ID: 24982881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.
    Wells J; Haidaris CG; Wright TW; Gigliotti F
    Infect Immun; 2006 Apr; 74(4):2446-8. PubMed ID: 16552076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
    Shellito JE; Kolls JK; Olariu R; Beck JM
    J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.
    Empey KM; Hollifield M; Schuer K; Gigliotti F; Garvy BA
    Infect Immun; 2004 Nov; 72(11):6211-20. PubMed ID: 15501746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.
    Roths JB; Sidman CL
    J Clin Invest; 1992 Aug; 90(2):673-8. PubMed ID: 1353767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.